Analysis on whether fezolinetant tablets can be purchased in the country and its legality

Fezolinetant (fezolinetant) is a new oral neurokinin receptor antagonist, mainly used to treat menopausal-related hot flashes. Although the drug is gradually gaining attention and recognition internationally, it has not yet been officially launched in China. This means that domestic patients are temporarily unable to purchase the drug directly through formal medical channels.

Since Fezonatant has not been approved by the national drug regulatory authorities, its domestic sales and circulation are not yet legal. If patients need to use the drug, they usually need to rely on overseas channels or purchasing agents. Special attention needs to be paid to the fact that there are certain legal and security risks associated with cross-border drug purchases. Patients should carefully choose formal and trustworthy channels to avoid purchasing counterfeit and shoddy products.

It is understood that in overseas markets, generic versions of Fezonastat are already on the market. For example, the generic version produced by Lucius Pharmaceutical Factory in Laos is 45mg*30 tablets, and the price is about 900 yuan. This price is more competitive than the original drug, providing an optional alternative for patients with limited financial conditions. At the same time, the efficacy and safety of these generic drugs have usually been verified to a certain extent, and they have certain guarantees for use.

Generally speaking, fezonatant is not yet on the market in China and there are no legal purchasing channels. If patients need the drug, they should carefully consider obtaining it through formal overseas channels under the guidance of a doctor. At the same time, with more clinical data and approval progress, Fezonatan is expected to enter the domestic market in the future, providing patients with more convenient and safer treatment options.

Reference materials:https://www.drugs.com/